The global oxygen concentrators market, valued at US$1.1 billion in 2024, reached US$1.2 billion in 2025 and is projected to advance at a resilient CAGR of 6.1% from 2025 to 2030, culminating in a forecasted valuation of US$1.7 billion by 2030.
As air pollution and smoking rates rise globally—particularly in urban and industrial areas—respiratory diseases such as COPD and asthma are becoming increasingly prevalent. This has fueled a growing demand for oxygen concentrators, especially in countries like India and China, where high pollution levels and smoking-related health burdens are leading to wider adoption of oxygen therapy.
Growing awareness, earlier diagnosis, and a shift toward home healthcare are further strengthening the market outlook.
Key Market Dynamics
Drivers: Rising Prevalence of Respiratory Diseases
Chronic respiratory diseases are a major global health burden. According to the Global Burden of Disease Study, COPD alone accounts for more than 3 million deaths annually, ranking among the leading causes of mortality.
- Factors such as smoking, poor air quality, industrial emissions, and aging populations are accelerating respiratory disease incidence.
- The Asia Pacific region, especially India and China, faces heightened risks due to severe urban air pollution and rapid industrialization, thereby driving oxygen concentrator demand.
Restraints: Dependence on Stable Power Supply
While oxygen concentrators are life-saving, their reliance on continuous electricity poses significant challenges in low-resource regions.
- Areas with frequent power outages—such as rural India, Sub-Saharan Africa, and Southeast Asia—struggle to maintain consistent oxygen delivery.
- Backup solutions like generators or solar systems add complexity and cost, limiting widespread adoption in underserved regions.
Opportunities: Growth in Emerging Markets
Emerging economies in Asia Pacific, Latin America, and Africa represent untapped potential due to:
- Expanding middle-class populations with rising health awareness
- Increased public and private healthcare investments
- Growing insurance coverage and affordable access to long-term respiratory care
- Rapid urbanization fueling higher pollution levels and associated lung diseases
Challenges: Integration with Telehealth & Remote Monitoring
The digital transformation of healthcare presents both challenges and opportunities:
- Next-generation concentrators with remote monitoring and telehealth integration allow real-time tracking of oxygen use and patient vitals.
- This is particularly valuable in home healthcare settings, enabling clinicians to manage patients remotely, reduce hospital visits, and improve outcomes.
- The post-COVID era has accelerated the shift toward connected respiratory care, with insurers increasingly supporting remote therapy.
Market Segmentation Insights
- By Type: Portable oxygen concentrators (POCs) are expected to dominate from 2025 to 2030. Lightweight, mobile, and battery-operated, POCs provide independence for patients while enabling continuous therapy outside hospitals.
- By End User: Home care settings hold the largest share, driven by cost efficiency, patient comfort, and insurer support. Telehealth advancements are making home-based oxygen therapy safer and more effective.
- By Region:
- Asia Pacific will lead the global market, fueled by a large patient base, rising income levels, and government-backed healthcare investments.
- Europe benefits from strong infrastructure, favorable reimbursement, and high geriatric health awareness.
- North America maintains steady growth due to advanced technologies and high adoption rates of portable concentrators.
Recent Developments
- June 2025: Inogen, Inc. introduced the Voxi 5 Stationary Oxygen Concentrator, focusing on affordability and long-term care.
- January 2025: CAIRE Inc. launched the IntenOxy 5, offering up to 95.5% oxygen concentration with flexible flow settings.
- October 2024: Inogen unveiled the Rove 4 Portable Oxygen Concentrator, delivering the highest oxygen output in the lightest weight model, powered by its patented pulse-dose technology.
Conclusion
The oxygen concentrators market is on a strong growth trajectory, driven by rising respiratory disease prevalence, increasing healthcare access in emerging markets, and technological advances in portable and connected devices.
With Asia Pacific leading in demand and home healthcare adoption becoming mainstream worldwide, opportunities for innovation and expansion are immense. However, addressing power supply limitations and improving affordability in underserved regions remain critical to ensuring that oxygen therapy reaches all who need it.
Marke an enquire to buy this Report
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/oxygen-concentrator-market-199087330.html
